Novel treatment of elbow dysplasia and associated osteoarthritis
A pilot study to assess the efficacy of 2.5% PAAG in 20 Labrador Retrievers with Elbow Dysplasia (2017-2018) and associated Osteoarthritis. Background: 20 Labrador Retriever dogs with moderate to severe…
Novel treatment of elbow osteoarthritis in an 8yr old dog
Dora, an 8 year old mastiff x staffy bitch had been suffering from bilateral elbow osteoarthritis for approximately two years. She required regular (up to weekly) meloxicam administration to maintain…
Treatment of fetlock lameness in a Thoroughbred racehorse
Skiddy, a 3 year old Thoroughbred gelding had presented severely lame in the left forelimb after galloping around a paddock whilst having a spell from race training. Radiographs identified a…
Treatment of fetlock lameness using Arthramid Vet 2.5% PAAG
Dream was a 2-year-old Thoroughbred in full race training that started to resent being ridden and over space of 4 weeks developed swelling of the left fore fetlock. Examination: Physical…
Treatment of coffin (DIP) joint lameness using Arthramid Vet 2.5% PAAG
Equine veterinarians are reporting that a 2.5% hydrogel originally designed as a cosmetic filler can help horses with early stage to chronic osteoarthritis (OA). In the latest of our series…
Treatment of Osteoarthritis of the Tarsometatarsal (TMT) Joint in a Horse
The latest treatment for hock joint pain and lameness in horses now includes the use of 2.5% PAAG Arthramid Vet. The next in our series of case reports is a…
Treatment of intercarpal joint lameness using Arthramid Vet 2.5% PAAG
Elmo was a 7-year-old Warmblood-Thoroughbred cross gelding competing at the height of 1.4m in Showjumping. Over 12 weeks, his performance reduced to a point where he started to resent training…
Treatment of joint lameness and osteoarthritis (OA) in horses
Osteoarthritis (OA) is considered one of the most important musculoskeletal disorders in both humans and horses. Clinically, it is associated with lameness and dysfunction of the affected joint and approximately…
Treatment of intercarpal (knee) joint lameness in TB racehorses
Use Of a 2.5% Cross-Linked Polyacrylamide Hydrogel In The Management Of Joint Lameness In a Population Of Flat Racing Thoroughbreds: A Pilot Sudy Published in JEVS; Read here Abstract Osteoarthritis…
Clinical Safety of Arthramid Vet 2.5% PAAG Hydrogel
Multiple studies have now shown that 2.5% PAAG is safe for use in animals and humans. Both in vitro and in vivo studies have taken place, designed to generate data…
Arthramid Vet 2.5% PAAG Hydrogel- Efficacy Study
Intra-articular administration of a 2.5% polyacrylamide hydrogel (PAAG- Arthramid Vet) is shown to reduce or abolish lameness in distal interphalangeal (coffin) and metacarpo/ metatarso- phalangeal (fetlock) joints in horses undertaking…
Arthramid Vet 2.5% PAAG – Mechanism Of Action
The mechanism of action of 2.5% PAAG appears multifaceted. Osteoarthritis (OA) describes inflammation of a joint and occurs after single or repetitive episodes of trauma. The term incorporates synovitis, capsulitis,…
